Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Dying to be thin? The FDA must regulate counterfeit weight loss drugs, says AG Bonta | Opinion
More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...
Colorado Public Radio6h
Weight-loss drugs could revolutionize treatment for alcohol addiction
Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
How GLP-1 Drugs Could Revolutionize Retirement
The rise in GLP-1 drugs is undeniable. Morgan Stanley projects that by 2035, 24 million Americans, or 7% of the population, ...
Axios on MSN17h
Ozempic and Wegovy shortage ends, setting up weight loss drug showdown
Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...
Ozempic being ‘sold by drug dealers alongside Class As’
Ozempic being ‘sold by drug dealers alongside Class As’ - Weight-loss drugs and prescription medications for ADHD are among ...
Utah’s attorney general targets safety issues over weight loss drugs
Utah’s Attorney General Derek Brown signed onto a letter along with attorneys general from 37 other states to ask the Food and Drug Administration to enforce the safety of weight loss drugs.